Raymond James analyst John Ransom maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $90 to $85.
Raymond James analyst John Ransom maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $90 to $85.